Researchers in the United Kingdom have put an abrupt stop to an arm of their Covid-19 trial that involves the antimalarial drug hydroxychloroquine
The Recovery trial, a large UK-based trial investigating potential coronavirus treatments, has stopped including hydroxychloroquine in its study due to there being"no evidence of benefit," researchers announced on Friday. Other arms in the trial, which has enrolled more than 11,000 patients from 175 hospitals across the UK, will continue.
"As Solidarity and Recovery are two of the larger trials, and moreover they have very, very similar study designs, we have been in touch," Dr. Soumya Swaminathan, WHO chief scientist, said during the briefing."They informed us about the preliminary results, which they have gone to the press with.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
UK halts trial of hydroxychloroquine as 'useless' for COVID-19 patientsBritish scientists halted a major drug trial on Friday after it found that the anti-malarial hydroxychloroquine, touted by U.S. President Donald Trump as a potential 'game changer' in the pandemic, was 'useless' at treating COVID-19 patients.
続きを読む »
UK business minister Alok Sharma tests negative for COVID-19British business minister Alok Sharma said he had tested negative for COVID-19, in a statement posted on Twitter a day after he had been taken ill inside parliament.
続きを読む »
WHO set to resume hydroxychloroquine trial in battle against COVID-19The World Health Organization will resume its trial of hydroxychloroquine for potential use against the coronavirus, its chief said on Wednesday, after those running the study briefly stopped giving it to new patients over health concerns.
続きを読む »
WHO set to resume hydroxychloroquine trial in battle against COVID-19The World Health Organization will resume its trial of hydroxychloroquine for potential use against the coronavirus, its chief said on Wednesday, after those running the study briefly stopped giving it to new patients over health concerns.
続きを読む »
Hydroxychloroquine fails to prevent COVID-19, large study findsThe findings come from a highly anticipated clinical trial looking at whether the antimalarial drug touted by President Donald Trump might prevent the illness caused by the coronavirus.
続きを読む »